Exagen inc. appoints paul kim to board of directors

San diego, july 24, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced today that paul kim has been appointed as a member of the exagen board of directors, effective july 24, 2023.

XGN Ratings Summary

XGN Quant Ranking